Vaccine Maintenance Treatment for Non-Small Cell Lung Cancer

Summary

To determine the response rate of the administration of HyperAcute-Lung Cancer Vaccine for subjects with stage IIIB or stage IV non-small cell lung cancer who have been treated with first line platinum-doublet therapy and have responded or are considered to have stable disease.

Timeline

Start

2007-01

Primary completion

2012-11

Completion

2014-12

Outcome

Outcome not reported

Stopped (Enrollment): “Enrollment goals unable to be reached.”

Drugs

Indications